Regulatory Considerations for Genome-Edited T-cell Therapies
2024 · Cancer Immunology Research · 7 citations
https://doi.org/10.1158/2326-6066.cir-24-0482
J
Ju-Fang Chang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
46
Citations
3
h-index
1
i10-index
Ju-Fang Chang is an academic researcher. The author has contributed to research in topics: CAR-T cell therapy research & vaccines and immunoinformatics approaches & Transgenic Plants and Applications. The author has an h-index of 3, co-authored 19 publications.
ORCID: 0009-0007-4050-937XPapers by this author
worksSupplementary Figure 1 from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024 · 0 citations
https://doi.org/10.1158/2326-6066.26926063.v1
Data from Identification of Core Techniques That Enhance Genome Editing of Human T Cells Expressing Synthetic Antigen Receptors
2024 · 0 citations
https://doi.org/10.1158/2326-6066.c.7429375
Supplementary Figure 7 from Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27434308
Supplementary Figure 8 from Rational Protein Engineering to Enhance MHC-Independent T-cell Receptors
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27434305
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat